ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
Raj143
|
33 |
16K |
1 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
33
|
16K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Pre-Spud Operations On Track
|
|
Raj143
|
114 |
50K |
0 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
114
|
50K
|
0
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Pre-Spud Operations On Track
|
|
Raj143
|
114 |
50K |
4 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
114
|
50K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
Raj143
|
33 |
16K |
0 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
33
|
16K
|
0
|
|
ASX - By Stock
|
88E |
Re:
News: 88E 88 Energy Says Alaskan Department Of Natural Resources Approved Formation Of Toolik River...
|
|
Raj143
|
29 |
18K |
0 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
29
|
18K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of US retail generics business
|
|
Raj143
|
61 |
32K |
4 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
61
|
32K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of US retail generics business
|
|
Raj143
|
61 |
32K |
4 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
61
|
32K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of US retail generics business
|
|
Raj143
|
61 |
32K |
8 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
61
|
32K
|
8
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma announces sale of US retail generics business
|
|
Raj143
|
61 |
32K |
4 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
61
|
32K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Pause in Trading
|
|
Raj143
|
10 |
4.0K |
3 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
10
|
4.0K
|
3
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
1 |
26/02/23 |
26/02/23 |
ASX - By Stock
|
172
|
71K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
2 |
26/02/23 |
26/02/23 |
ASX - By Stock
|
172
|
71K
|
2
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
1 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
172
|
71K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
2 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
172
|
71K
|
2
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
0 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
172
|
71K
|
0
|
|
ASX - By Stock
|
88E |
Re:
Toolik river unit (Icewine)
|
|
Raj143
|
17 |
9.1K |
0 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
17
|
9.1K
|
0
|
|
ASX - By Stock
|
88E |
Re:
Toolik river unit (Icewine)
|
|
Raj143
|
17 |
9.1K |
0 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
17
|
9.1K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Raj143
|
82K |
49M |
0 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
82K
|
49M
|
0
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
5 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
172
|
71K
|
5
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory - 1 Operations Update
|
|
Raj143
|
172 |
71K |
0 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
172
|
71K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma to restate US dermatology net revenue for FY22
|
|
Raj143
|
46 |
19K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
46
|
19K
|
1
|
|
ASX - By Stock
|
88E |
Re:
share placement
|
|
Raj143
|
52 |
20K |
0 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
52
|
20K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Some Analysis
|
|
Raj143
|
78 |
32K |
5 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
78
|
32K
|
5
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Raj143
|
323 |
123K |
1 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
323
|
123K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Some Analysis
|
|
Raj143
|
78 |
32K |
0 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
78
|
32K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Raj143
|
323 |
123K |
1 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
323
|
123K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Raj143
|
82K |
49M |
0 |
04/02/23 |
04/02/23 |
ASX - By Stock
|
82K
|
49M
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Some Analysis
|
|
Raj143
|
78 |
32K |
6 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
78
|
32K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
Raj143
|
98 |
47K |
0 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
98
|
47K
|
0
|
|
ASX - By Stock
|
S32 |
Re:
Sierra Gorda copper mine
|
|
Raj143
|
121 |
73K |
1 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
121
|
73K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
Raj143
|
98 |
47K |
3 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
98
|
47K
|
3
|
|
ASX - By Stock
|
AVZ |
Re:
Running discussion on SP
|
|
Raj143
|
82K |
49M |
9 |
29/01/23 |
29/01/23 |
ASX - By Stock
|
82K
|
49M
|
9
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
Raj143
|
98 |
47K |
0 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
98
|
47K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
Raj143
|
98 |
47K |
2 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
98
|
47K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Return of Capital - MYX (updated)
|
|
Raj143
|
98 |
47K |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
98
|
47K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
what happens after consolidation ?
|
|
Raj143
|
12 |
11K |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
12
|
11K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Raj143
|
57 |
32K |
4 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
57
|
32K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on capital management timeline
|
|
Raj143
|
57 |
32K |
3 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
57
|
32K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Raj143
|
44 |
20K |
1 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
44
|
20K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Raj143
|
44 |
20K |
3 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
44
|
20K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Raj143
|
44 |
20K |
3 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
44
|
20K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX completes TherapeuticsMD product licensing transaction
|
|
Raj143
|
44 |
20K |
0 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
44
|
20K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Response to Media Speculation
|
|
Raj143
|
183 |
52K |
1 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
183
|
52K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Disclosure Clarifications - AFR Article
|
|
Raj143
|
304 |
136K |
17 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
304
|
136K
|
17
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Raj143
|
197 |
75K |
1 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
197
|
75K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Raj143
|
197 |
75K |
0 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
197
|
75K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: DRC General Inspectorate of Finance Report
|
|
Raj143
|
135 |
74K |
0 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
135
|
74K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: DRC General Inspectorate of Finance Report
|
|
Raj143
|
135 |
74K |
2 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
135
|
74K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: MYX signs license agreement for women's health products
|
|
Raj143
|
197 |
75K |
4 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
197
|
75K
|
4
|
|
ASX - By Stock
|
MYX |
Re:
Ann: AGM presentation and business and trading update
|
|
Raj143
|
73 |
35K |
5 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
73
|
35K
|
5
|
|